C1q and HBHA-specific IL-13 levels as surrogate plasma biomarkers for monitoring tuberculosis treatment efficacy: a cross-sectional cohort study in Paraguay
Correspondence: Graciela Russomando, grusso@rieder.net.py; Jonathan Hoffmann, jonathan.hoffmann@fondation-merieux.org
Spremljeno u:
| Glavni autor: | |
|---|---|
| Daljnji autori: | , , , , , , , , , , , |
| Format: | article |
| Jezik: | engleski |
| Izdano: |
2024
|
| Teme: | |
| Online pristup: | https://doi.org/10.3389/fimmu.2024.1308015 http://hdl.handle.net/20.500.14066/4587 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|
Budi prvi tko komentira!